Share Buyback Programme

Venture Life Group plc (AIM: VLG), a recognised leader in proactive healthy longevity, product innovation, development, and commercialisation within the global consumer healthcare sector, is pleased to announce that, following publication of the Company's interim results for the six months ended 30 June 2025, it will commence a share buyback programme (the "Programme") with immediate effect.

The Board believes that Venture Life's Ordinary Shares are undervalued relative to the Group's strong fundamentals and growth potential. By undertaking the Programme, the Company aims to enhance earnings per share and deliver greater value to its shareholders. The Programme will be funded from the Company's existing cash resources and is intended to reduce the share capital of the Company.

Pursuant to the terms of the Programme, the Company is seeking to repurchase up to 12,805,231 ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares"), representing approximately 10 per cent. of the Company's existing issued share capital, in the market over the course of the period from the date of this announcement until 31 July 2026 (the "Expiry Date").

Ordinary Share repurchases will be made pursuant to the buyback authority granted at the Company's last Annual General Meeting. The maximum price which may be paid by the Company per Ordinary Share pursuant to the Programme shall not be more than 5 per cent above the average middle market quotations for an Ordinary Share (as derived from the London Stock Exchange AIM All-Share List) for the five business days immediately preceding the date on which such share is contracted to be purchased.

The Company has appointed Cavendish Capital Markets Limited ("Cavendish") to manage the Programme on its behalf on a broker-managed basis, with trading decisions taken independently of, and uninfluenced by, the Company. There is no certainty that the Programme will be completed and it may be paused at any time if deemed appropriate by Cavendish with respect to market conditions.

Venture Life intends to hold all of the repurchased Ordinary Shares as Treasury Shares.

As at 29 September 2025, the Company's total issued share capital consisted of 128,052,312 Ordinary Shares, with one voting right per share. As at this date the Group did not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Group is 128,052,312.